mental retardation: ['Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual is mentally retarded. IQ scores between 70 and 79 are in the borderline mentally retarded range. Scores below 67 are in the retarded range. (Joynt, Clinical Neurology, 1992, Ch55, p28)']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
968 |
4. Check minimum number of eventsNone |
968 |
5. Include endpointsNone |
968 |
6. Filter based on genotype QC (FinnGen only) |
968 |
Control definitions (FinnGen only)
- Control exclude
- F5_MENTRET
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F70-F79
- Name in latin
- Retardatio mentalis levis
Similar endpoints
↥List of similar endpoints to
Mild mental retardation
based on the number of shared cases.
Similar with more cases:
- Mental retardation
- Mental retardation, excluding more controls
- Mental retardation, wide definition
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 22488 | 9950 | 12449 |
| Only index persons | 19541 | 8687 | 10854 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.32 | 0.28 | 0.35 |
| Only index persons | 0.37 | 0.32 | 0.41 |
| Median age at first event (years) | |||
| Whole population | 18.73 | 21.41 | 16.40 |
| Only index persons | 18.04 | 20.26 | 16.27 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 968 | 488 | 480 |
| Unadjusted period prevalence (%) | 0.19 | 0.17 | 0.21 |
| Median age at first event (years) | 25.38 | 26.03 | 24.72 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 909
- Matched controls
- 9088
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
10159.4
323.0
502
*
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
+∞
286.0
259
*
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
2733.1
241.8
223
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
14.8
188.4
345
360
N05AX08
ATC
risperidone; systemic
15.0
170.9
307
298
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
+∞
144.7
135
*
N03AG01
ATC
valproic acid; systemic, rectal
13.9
138.6
254
246
F83
ICD-10 Finland
Mixed specific developmental disorders
33.8
133.4
176
64
N05AH03
ATC
olanzapine; systemic
11.8
130.4
261
301
3170A
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,EI KÄYTÄYTYM.HÄIRIÖTÄ]
+∞
111.8
105
*
N05AA02
ATC
levomepromazine; systemic
13.3
97.1
178
163
F20.9
ICD-10 Finland
Schizophrenia, unspecified
20.2
91.8
141
82
N05BA01
ATC
diazepam; systemic, rectal
6.7
90.9
264
526
P85
ICPC
Mental retardation
477.2
88.8
87
*
N04AA02
ATC
biperiden; systemic
25.5
88.8
126
57
F29
ICD-10 Finland
Unspecified nonorganic psychosis
11.4
87.9
174
185
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
10.6
87.6
181
209
N05AC02
ATC
thioridazine; oral
23.1
84.1
123
61
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
6.6
80.4
230
441
31199
ICD-8 Finland
Mild mental retardation, Other and unspecified
+∞
75.0
71
*
N05AF03
ATC
chlorprothixene; systemic
15.7
72.5
122
89
F70
ICD-10 Finland
Mild mental retardation
755.5
72.2
70
*
N05AB03
ATC
perphenazine; systemic, rectal
13.2
71.7
130
113
N05AH04
ATC
quetiapine; oral
4.5
70.9
308
936
G40.9
ICD-10 Finland
Epilepsy, unspecified
13.1
70.8
129
113
N05BA06
ATC
lorazepam; systemic, sublingual
11.4
69.0
135
137
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
697.2
66.8
65
*
N05AD01
ATC
haloperidol; systemic
15.9
66.5
111
79
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
15.9
66.5
111
79
3170B
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,JOSSA KÄYTÄYTYM.HÄIRI]
+∞
64.3
61
*
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
64.3
61
*
N05AX12
ATC
aripiprazole; systemic
8.0
63.0
152
222
N05AH02
ATC
clozapine; systemic
12.6
61.7
114
102
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
17.9
59.8
95
59
A06AD11
ATC
lactulose; oral
5.7
59.1
188
399
P72
ICPC
Schizophrenia
15.5
56.1
94
67
N03AF01
ATC
carbamazepine; oral, rectal
9.9
53.9
113
129
183
Kela drug reimbursment
Lamotrigin and topiramate
22.5
47.3
69
33
N05CD07
ATC
temazepam; oral
5.3
46.8
154
334
N06AB04
ATC
citalopram; systemic
3.6
46.6
254
892
31099
ICD-8 Finland
Borderline mental retardation, Other and unspecified
241.9
45.4
46
*
N05AF05
ATC
zuclopenthixol; systemic
21.5
44.6
66
33
N05BA09
ATC
clobazam; oral
31.4
44.5
59
20
N03AF02
ATC
oxcarbazepine; oral
8.2
43.0
100
135
A28
ICPC
Limited function/disability NOS
4.5
42.1
163
418
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
42.0
40
*
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
+∞
40.9
39
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.6
40.7
127
257
N03AX09
ATC
lamotrigine; oral
5.9
40.3
119
225
R62.0
ICD-10 Finland
Delayed milestone
13.2
39.8
71
58
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
37.6
244
951
P99
ICPC
Psychological disorders other
7.4
37.2
92
136
N05BA04
ATC
oxazepam; oral
2.9
37.0
269
1135
SPAT1234
SPAT
Support of social functional capacity
7.4
35.9
89
132
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.8
35.8
67
61
OAB43
SPAT
NA
0.1
34.2
7
1027
N05AA01
ATC
chlorpromazine; systemic, rectal
14.2
32.1
55
41
EBA00
NOMESCO Finland
Extraction of tooth
2.4
31.9
406
2308
188
Kela drug reimbursment
Psychosis requiring demanding treatment
17.0
31.4
50
31
N03AX11
ATC
topiramate; oral
8.4
30.2
68
87
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
160.3
29.8
31
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.6
29.1
57
57
C03CA01
ATC
furosemide; systemic
3.0
29.0
194
760
SPAT1301
SPAT
No procedures
2.4
28.9
337
1810
N03AX14
ATC
levetiracetam; systemic
8.6
28.5
63
78
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.7
28.3
223
966
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
3.0
28.0
181
690
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.3
27.9
155
532
M03BX02
ATC
tizanidine; oral
0.4
27.7
202
3668
N05CD08
ATC
midazolam; nasal, systemic
8.8
27.7
60
72
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
23.9
27.6
39
17
31109
ICD-8 Finland
Mild mental retardation, Following infections and intoxications, Unspecified
+∞
27.2
26
*
A10BA02
ATC
metformin; oral
2.7
27.0
220
966
F20.5
ICD-10 Finland
Residual schizophrenia
42.7
26.9
33
8
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
26.8
178
689
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.3
26.6
104
265
P29
ICPC
Psychological sympt/compl other
3.8
26.5
119
343
K03.66
ICD-10 Finland
Tooth plaque
3.5
26.5
136
438
SPAT1254
SPAT
Administration of medicine
2.8
26.4
198
828
30180
ICD-8 Finland
Personality disorders, Immatura
61.9
26.1
30
5
XA800
NOMESCO Finland
Neuropsychological investigation
4.7
26.1
92
211
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
17.1
26.0
41
25
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
15.0
25.9
43
30
Z2446
NOMESCO Finland
Social worker
3.5
25.9
132
423
N05AD03
ATC
melperone; systemic
20.8
25.8
38
19
N03AG04
ATC
vigabatrin; oral
96.2
25.8
28
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.8
25.6
182
736
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.7
25.4
90
207
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
51.6
25.4
30
6
29599
ICD-8 Finland
Schizophrenia, Unspecified type
36.8
25.3
32
9
SPAT1262
SPAT
Handing over of treatment supplies
2.9
25.2
169
656
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.8
25.2
73
134
SPAT1229
SPAT
Assessment of need for aid
4.6
24.6
88
205
31100
ICD-8 Finland
Mild mental retardation, Following infections and intoxications, Post infectionem praenatalem
+∞
24.1
23
*
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
19.7
24.1
36
19
103
Kela drug reimbursment
Diabetes, insulin-treated
2.5
23.1
215
1008
F71.9
ICD-10 Finland
Moderate mental retardation, without mention of impairment of behaviour
+∞
23.0
22
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.8
23.0
102
291
H13
ICPC
Plugged feeling ear
2.8
22.9
168
688
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.9
22.9
155
605
A46
ICD-10 Finland
Erysipelas
3.2
22.7
131
456
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.5
22.5
68
131
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.2
22.1
71
147
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
22.0
21
*
H50.31
ICD-10 Finland
Intermittent exotropia
11.2
21.8
41
38
F61.0
ICD-10 Finland
Mixed personality disorders
8.4
21.7
48
60
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
21.6
146
565
N05AN01
ATC
lithium; oral
6.3
21.5
58
97
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
21.5
159
652
N03AE01
ATC
clonazepam; systemic
4.5
21.5
78
184
P28
ICPC
Limited function/disability (P)
13.2
21.3
37
29
R11
ICD-10 Finland
Nausea and vomiting
3.3
21.2
115
384
U04
ICPC
Incontinence urine
6.3
21.1
57
96
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.7
20.8
95
277
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
8.1
20.8
47
61
29999
ICD-8 Finland
Unspecified psychosis
78.7
20.8
23
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.2
20.5
117
405
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
20.6
20.5
30
15
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
20.4
125
454
SPAT1263
SPAT
Sampling
2.0
20.3
402
2611
T90
ICPC
Diabetes non-insulin dependent
2.5
20.2
176
789
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.9
20.1
46
61
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
10.4
20.0
39
39
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.9
19.9
129
485
N05AL01
ATC
sulpiride; systemic
15.7
19.9
32
21
M01AH05
ATC
etoricoxib; oral
0.5
19.8
200
3364
F82
ICD-10 Finland
Specific developmental disorder of motor function
9.3
19.8
41
46
181
Kela drug reimbursment
Retigabine and vigabatrin
107.4
19.6
21
*
31009
ICD-8 Finland
Borderline mental retardation, Following infections and intoxications, Unspecified
204.3
19.6
20
*
G40.89
ICD-10 Finland
Other epilepsy
22.2
19.6
28
13
F80.1
ICD-10 Finland
Expressive language disorder
7.8
19.6
45
60
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.4
19.5
196
948
F20
ICD-10 Finland
Schizophrenia
15.0
19.5
32
22
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.2
19.2
52
88
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.6
19.1
155
669
34599
ICD-8 Finland
Epilepsy, Other and unspecified
35.2
19.0
24
7
WYA20
NOMESCO Finland
Home visit
10.7
18.8
36
35
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
71.4
18.8
21
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
7.5
18.7
44
61
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.1
18.6
110
390
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.3
18.5
71
177
L28
ICPC
Limited function/disability (L)
2.8
18.5
126
489
N05AX13
ATC
paliperidone; systemic
13.9
18.3
31
23
RT150
NOMESCO Finland
NA
18.0
18.3
28
16
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.7
18.3
138
570
N06AB03
ATC
fluoxetine; oral
2.6
18.2
141
592
F22.0
ICD-10 Finland
Delusional disorder
9.4
18.0
37
41
SPAT1240
SPAT
Therapeutic discussion
2.6
18.0
147
635
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
16.9
17.9
28
17
N88
ICPC
Epilepsy
18.5
17.9
27
15
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
17.8
253
1425
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
17.8
17
*
K59.0
ICD-10 Finland
Constipation
4.2
17.7
69
175
N05AC01
ATC
periciazine; systemic
24.6
17.4
24
10
G03DC03
ATC
lynestrenol; oral
6.9
17.3
43
65
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
15.2
17.2
28
19
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.6
17.1
134
564
N06AB06
ATC
sertraline; oral
2.6
17.1
131
546
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
51.0
17.0
20
*
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
26.2
17.0
23
9
H81
ICPC
Excessive ear wax
2.7
16.8
126
518
P98
ICPC
Psychosis NOS/other
11.9
16.6
30
26
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
9.7
16.5
33
35
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
16.5
97
340
N03AX15
ATC
zonisamide; oral
40.9
16.4
20
5
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
16.3
75
220
N05AF01
ATC
flupentixol; systemic
10.7
16.3
31
30
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
16.3
113
443
Z2445
NOMESCO Finland
Psychologist
3.2
16.2
90
304
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
11.9
16.1
29
25
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
16.0
362
2407
Z72.8
ICD-10 Finland
Other problems related to lifestyle
12.5
15.9
28
23
R60.0
ICD-10 Finland
Localized oedema
3.1
15.9
92
321
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.6
15.8
72
210
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.2
15.8
190
992
F99
ICD-10 Finland
Mental disorder, not otherwise specified
5.4
15.6
47
91
N07BB01
ATC
disulfiram; oral
3.7
15.5
68
192
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
16.4
15.3
24
15
SPAT1100
SPAT
Long-term monitoring of blood pressure
4.0
15.0
61
161
Z31.5
ICD-10 Finland
Genetic counselling
3.3
15.0
79
258
SDA02
NOMESCO Finland
Parodonthologic therapy
1.8
14.9
323
2100
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
11.6
14.8
27
24
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
57.7
14.8
17
*
F28
ICD-10 Finland
Other nonorganic psychotic disorders
18.8
14.7
22
12
F20.0
ICD-10 Finland
Paranoid schizophrenia
12.1
14.6
26
22
3199A
ICD-9 Finland
Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS,EI KÄYTTÄYTYMIHÄIRI]
+∞
14.6
14
*
31000
ICD-8 Finland
Borderline mental retardation, Following infections and intoxications, Post infectionem praenatalem
+∞
14.6
14
*
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
81.5
14.6
16
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.0
14.6
209
1169
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
5.6
14.5
42
78
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.3
14.5
33
1014
7834D
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]
152.4
14.5
15
*
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
36.7
14.5
18
5
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
14.5
96
366
A29
ICPC
General symptom/complaint other
2.6
14.4
110
457
SPAT1252
SPAT
Overall medication plan or its review
3.8
14.4
61
168
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
6.0
14.3
39
67
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
14.3
226
1310
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.7
14.3
101
398
RL140
NOMESCO Finland
NA
13.7
14.3
24
18
K08.3
ICD-10 Finland
Retained dental root
3.4
14.1
70
219
OAB48
SPAT
NA
0.1
14.1
6
509
F21
ICD-10 Finland
Schizotypal disorder
10.3
14.0
27
27
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
10.3
14.0
27
27
F60.8
ICD-10 Finland
Other specific personality disorders
9.6
14.0
28
30
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
14.0
97
380
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
16.1
14.0
22
14
SPAT1260
SPAT
Consultation of another employee
2.1
13.9
168
874
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
30.6
13.9
18
6
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.3
13.9
42
1132
N05BE01
ATC
buspirone; oral
4.3
13.9
51
123
N06BA04
ATC
methylphenidate; oral
3.6
13.8
63
184
R1260
NOMESCO Finland
Evaluation of communicative skills
7.5
13.8
32
44
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
9.3
13.8
28
31
K59.09
ICD-10 Finland
Constipation, unspecified
3.4
13.8
68
212
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
5.4
13.8
41
79
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
13.8
166
860
M41.4
ICD-10 Finland
Neuromuscular scoliosis
142.0
13.5
14
*
RS222
NOMESCO Finland
NA
7.4
13.3
31
43
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
10.7
13.3
25
24
N03AX18
ATC
lacosamide; systemic
14.1
13.3
22
16
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
9.9
13.3
26
27
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
13.3
92
359
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.7
13.2
30
40
EBA30
NOMESCO Finland
Excision of root of tooth
3.8
13.1
56
155
2959A
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]
19.4
12.9
19
10
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.7
12.9
57
163
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
12.9
358
2493
G40.10
ICD-10 Finland
Simple partial seizures
10.7
12.8
24
23
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.8
12.7
82
307
Z00.0
ICD-10 Finland
General medical examination
2.0
12.7
178
982
SPAT1312
SPAT
General health counselling
1.7
12.7
330
2250
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.2
12.7
68
226
OAA65
SPAT
NA
0.1
12.7
8
519
Z28
ICPC
Limited function/disability (Z)
17.6
12.5
19
11
L17
ICPC
Foot/toe symptom/complaint
1.9
12.5
234
1432
F79
ICD-10 Finland
Unspecified mental retardation
131.8
12.5
13
*
T82
ICPC
Obesity
3.8
12.4
53
147
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
12.4
44
103
F20.10
ICD-10 Finland
Raise schizophrenia continuously
14.6
12.3
20
14
N03AB02
ATC
phenytoin; systemic
10.7
12.3
23
22
OAA67
SPAT
NA
0.1
12.2
*
390
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.0
12.1
38
78
SPAT1325
SPAT
Vaccination
1.7
12.1
298
1990
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
18.3
12.1
18
10
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
18.3
12.1
18
10
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
27.1
12.1
16
6
Z02.7
ICD-10 Finland
Issue of medical certificate
3.1
12.0
68
234
Z50.5
ICD-10 Finland
Speech therapy
4.7
11.8
39
85
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
9.8
11.8
23
24
ZY010
NOMESCO Finland
Hospital outpatient
2.6
11.8
85
342
SPAT1216
SPAT
Assessment of functional ability
2.4
11.8
107
486
M01AB05
ATC
diclofenac; systemic, rectal
0.6
11.7
279
3876
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.9
11.7
73
268
G41.9
ICD-10 Finland
Status epilepticus, unspecified
16.7
11.7
18
11
F20.8
ICD-10 Finland
Other schizophrenia
16.7
11.7
18
11
F84.0
ICD-10 Finland
Childhood autism
30.5
11.7
15
5
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
12.8
11.7
20
16
G04BD04
ATC
oxybutynin; oral, transdermal
3.8
11.6
48
130
F80.2
ICD-10 Finland
Receptive language disorder
7.3
11.6
27
38
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.0
11.6
171
959
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
11.5
282
1874
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
6.8
11.5
28
42
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
6.8
11.5
28
42
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.2
11.5
60
196
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
13.8
11.5
19
14
SPAT1167
SPAT
Insertion of urinary catheter
6.2
11.4
30
50
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.9
11.4
46
122
H50.1
ICD-10 Finland
Divergent concomitant strabismus
8.5
11.3
24
29
H52.2
ICD-10 Finland
Astigmatism
4.8
11.3
37
80
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.8
11.3
37
80
SPAT1244
SPAT
Occupational therapy
9.8
11.3
22
23
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.7
11.2
78
307
K02.1
ICD-10 Finland
Caries of dentine
1.6
11.2
545
4364
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.9
11.2
70
258
R53
ICD-10 Finland
Malaise and fatigue
1.9
11.2
170
962
N03AX22
ATC
perampanel; oral
25.4
11.2
15
6
A10BB01
ATC
glibenclamide; oral
6.2
11.1
29
48
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
11.0
100
456
Z29
ICPC
Social problem NOS
4.5
10.9
38
88
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
10.8
85
358
IGV01
NOMESCO Finland
Psychiatric network contact
5.3
10.8
32
62
R33
ICD-10 Finland
Retention of urine
3.2
10.8
55
177
Z02.4
ICD-10 Finland
Examination for driving licence
0.3
10.8
25
763
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
28.4
10.7
14
5
H03AA01
ATC
levothyroxine sodium; systemic
1.9
10.7
163
923
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.4
10.7
35
917
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.3
10.7
102
474
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.6
10.6
30
55
R55
ICD-10 Finland
Syncope and collapse
2.5
10.6
87
376
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.3
10.6
99
455
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.8
10.5
34
73
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
10.5
415
3127
A01
ICPC
Pain general/multiple sites
2.7
10.5
72
279
2956C
ICD-9 Finland
Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]
111.3
10.4
11
*
F71
ICD-10 Finland
Moderate mental retardation
+∞
10.4
10
*
31599
ICD-8 Finland
Unspecified mental retardation, Other and unspecified
+∞
10.4
10
*
N06AX16
ATC
venlafaxine; oral
2.1
10.4
125
645
SPAT1310
SPAT
Counselling related to known health issue
1.7
10.4
288
1973
SPAT1281
SPAT
Other administrative function
2.4
10.4
90
398
P50
ICPC
Psychological, Medication/prescr/renewal
16.3
10.4
16
10
N06AB05
ATC
paroxetine; oral
2.8
10.4
66
247
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
10.4
172
1004
29500
ICD-8 Finland
Schizophrenia, Simple type
32.9
10.3
13
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
10.3
105
503
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.5
10.3
48
144
29580
ICD-8 Finland
Schizophrenia, Other
19.0
10.3
15
8
3459X
ICD-9 Finland
Epilepsy, unspecified
23.7
10.3
14
6
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
10.2
63
229
AA1AD
NOMESCO Finland
CT of head and brain
1.9
10.2
164
943
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.0
10.2
131
693
N06AA04
ATC
clomipramine; systemic
6.0
10.2
27
46
A10AE04
ATC
insulin glargine; parenteral
2.5
10.2
80
335
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
10.2
89
397
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.9
10.1
63
231
N06AA12
ATC
doxepin; systemic
3.3
10.1
49
152
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
10.1
160
918
R50.9
ICD-10 Finland
Fever, unspecified
2.0
10.1
146
812
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.8
10.0
64
240
SPAT1251
SPAT
Organisation of medication
4.0
10.0
39
101
N06AX03
ATC
mianserin; oral
3.5
10.0
45
132
N03AD01
ATC
ethosuximide; oral
40.5
10.0
12
*
ZY000
NOMESCO Finland
Hospital inpatient
5.1
9.9
30
60
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
12.3
9.9
17
14
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
9.9
178
1069
R45.1
ICD-10 Finland
Restlessness and agitation
26.3
9.8
13
5
2959E
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]
26.3
9.8
13
5
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
20.3
9.8
14
7
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
6.6
9.8
24
37
A10BD07
ATC
metformin and sitagliptin; systemic
4.3
9.8
35
84
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
7.5
9.7
22
30
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
9.7
159
923
-1
ICPC
NA
5.6
9.7
27
49
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.4
9.7
81
354
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
55.6
9.7
11
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
9.6
121
634
OAA80
SPAT
NA
0.0
9.6
*
271
NB6AA
NOMESCO Finland
Humerus X-ray examination
6.5
9.6
24
38
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.4
9.6
45
137
X78
ICD-10 Finland
Intentional self-harm by sharp object
9.2
9.5
19
21
RS312
NOMESCO Finland
NA
15.2
9.5
15
10
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
9.5
382
2868
N06AA09
ATC
amitriptyline; systemic
2.5
9.5
73
303
R1250
NOMESCO Finland
Evaluation of functional capability
5.0
9.5
29
59
29560
ICD-8 Finland
Residual schizophrenia
101.1
9.4
10
*
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
30.4
9.4
12
*
F78.0
ICD-10 Finland
Other mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
9.4
9
*
N03AF03
ATC
rufinamide; oral
+∞
9.4
9
*
N03AX17
ATC
stiripentol; oral
+∞
9.4
9
*
F20.31
ICD-10 Finland
Undifferentiated schizophrenia periodically with gradual deterioration
+∞
9.4
9
*
A10BB12
ATC
glimepiride; oral
3.4
9.4
45
139
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
22.0
9.4
13
6
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
10.8
9.3
17
16
Z10.0
ICD-10 Finland
Occupational health examination
0.1
9.3
*
315
RT160
NOMESCO Finland
NA
9.6
9.3
18
19
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
9.6
9.3
18
19
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
13.8
9.2
15
11
F20.38
ICD-10 Finland
Undifferentiated schizophrenia other definite
13.8
9.2
15
11
K05.1
ICD-10 Finland
Chronic gingivitis
2.3
9.2
81
364
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
9.2
142
805
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.3
9.1
18
599
K05.18
ICD-10 Finland
Chronic gingivitis
2.7
9.1
59
224
N05AE03
ATC
sertindole; oral
11.6
9.1
16
14
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.5
9.1
41
121
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
9.2
9.1
18
20
N05BA05
ATC
potassium clorazepate; oral
10.2
9.0
17
17
A10BK03
ATC
empagliflozin; oral
2.9
9.0
56
204
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
37.1
9.0
11
*
F20.32
ICD-10 Finland
Undifferentiated schizophrenia stable periodically
37.1
9.0
11
*
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
37.1
9.0
11
*
N05BA02
ATC
chlordiazepoxide; systemic
4.6
9.0
30
67
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.9
9.0
137
771
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.5
9.0
41
122
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
24.3
8.9
12
5
34408
ICD-8 Finland
Other cerebral paralysis, Alia definita
24.3
8.9
12
5
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
8.9
312
2254
H61.2
ICD-10 Finland
Impacted cerumen
3.0
8.9
51
178
F91.9
ICD-10 Finland
Conduct disorder, unspecified
12.7
8.9
15
12
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
8.8
638
5459
G40
ICD-10 Finland
Epilepsy
10.8
8.8
16
15
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
9.6
8.8
17
18
Z03
ICPC
Housing/neighbourhood problem
9.6
8.8
17
18
R32
ICD-10 Finland
Unspecified urinary incontinence
4.8
8.8
28
60
30041
ICD-8 Finland
Neuroses, Depressiva
7.3
8.8
20
28
N30.0
ICD-10 Finland
Acute cystitis
2.1
8.8
99
498
SPAT1097
SPAT
Recording of ECG
2.1
8.7
96
474
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.6
8.7
29
65
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
4.6
8.7
29
65
R06.0
ICD-10 Finland
Dyspnoea
1.8
8.7
170
1046
S10
ICPC
Boil/carbuncle
2.9
8.7
51
182
N02AJ06
ATC
codeine and paracetamol; systemic
0.6
8.7
131
2066
H01
ICPC
Ear pain/earache
1.9
8.7
131
738
R41.0
ICD-10 Finland
Disorientation, unspecified
5.3
8.7
25
48
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.1
8.6
46
154
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.3
8.6
16
547
S22
ICPC
Nail symptom/complaint
2.7
8.6
58
224
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.4
8.6
74
328
J01FA10
ATC
azithromycin; systemic
0.7
8.6
363
4570
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
27.8
8.5
11
*
S06
ICPC
Rash localized
2.6
8.5
59
234
RT420
NOMESCO Finland
NA
20.2
8.5
12
6
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.3
8.4
30
72
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.4
8.4
39
118
H52.0
ICD-10 Finland
Hypermetropia
3.7
8.4
35
97
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
12.9
8.4
14
11
H47.2
ICD-10 Finland
Optic atrophy
12.9
8.4
14
11
R01AD09
ATC
mometasone; nasal
0.6
8.4
201
2849
R56.0
ICD-10 Finland
Febrile convulsions
5.3
8.3
24
46
F78.1
ICD-10 Finland
Other mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
8.3
8
*
30920
ICD-8 Finland
Mental disorders not specified as psychotic associated with physical conditions, Brain trauma
+∞
8.3
8
*
SPAT1139
SPAT
Nutrition survey
3.7
8.3
35
98
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
7.2
8.3
19
27
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
8.3
53
200
F61
ICD-10 Finland
Mixed and other personality disorders
14.6
8.2
13
9
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.2
8.1
29
70
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.5
8.1
65
1230
W19
ICD-10 Finland
Unspecified fall
2.1
8.1
88
435
WX110
NOMESCO Finland
Local anesthesy
1.5
8.1
617
5278
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
0.2
8.1
7
369
5210A
ICD-9 Finland
Diseases of hard tissues of teeth, Dental caries
33.7
8.1
10
*
F23.9
ICD-10 Finland
Acute and transient psychotic disorder, unspecified
33.7
8.1
10
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
8.1
181
1155
SPAT1235
SPAT
Mental health, emotional support
10.1
8.0
15
15
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
6.4
8.0
20
32
RT120
NOMESCO Finland
NA
22.2
8.0
11
5
29510
ICD-8 Finland
Schizophrenia, Hebephrenic type
22.2
8.0
11
5
R95
ICPC
Chron obstructive pulmonary disease
5.9
8.0
21
36
J01AA04
ATC
lymecycline; systemic
0.4
8.0
30
741
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
7.9
481
3912
R4120
NOMESCO Finland
Occupational therapy
2.4
7.8
63
269
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
8.6
7.8
16
19
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.6
7.8
206
1377
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
7.8
131
767
SPAT1307
SPAT
Psychosocial counselling and guidance
2.1
7.7
89
449
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
4.2
7.7
28
69
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
4.2
7.7
28
69
30899
ICD-8 Finland
Behaviour disorders of childhood
45.4
7.7
9
*
S97
ICPC
Chronic ulcer skin
3.1
7.7
41
138
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.3
7.7
21
599
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
0.6
7.7
168
2438
KMAK
NOMESCO Finland
NA
1.5
7.7
416
3293
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.3
7.6
15
497
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
7.6
73
342
602
Kela drug reimbursment
Children's severe malnutrition
5.0
7.6
23
47
N05AE04
ATC
ziprasidone; systemic
6.8
7.6
18
27
N03AX23
ATC
brivaracetam; systemic
18.5
7.6
11
6
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
12.0
7.6
13
11
RT130
NOMESCO Finland
NA
25.2
7.6
10
*
34532
ICD-8 Finland
Epilepsy, Partialis (focalis) generalisata
25.2
7.6
10
*
C09AA02
ATC
enalapril; systemic
2.0
7.6
104
564
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
6.2
7.6
19
31
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.4
7.6
26
61
WYA30
SPAT
NA
9.0
7.6
15
17
F89
ICD-10 Finland
Unspecified disorder of psychological development
9.0
7.6
15
17
L14
ICPC
Leg/thigh symptom/complaint
2.3
7.6
68
310
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
4.2
7.5
27
66
G04BD07
ATC
tolterodine; oral
3.4
7.5
35
107
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
0.2
7.5
11
427
A10BH01
ATC
sitagliptin; oral
2.4
7.5
59
252
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
7.5
76
364
NFL22
NOMESCO Finland
Myotomy or tenotomy of hip or thigh
80.7
7.4
8
*
G80.8
ICD-10 Finland
Other cerebral palsy
80.7
7.4
8
*
SPAT1304
SPAT
Counselling and guidance related to ageing
3.4
7.4
34
103
SPAT1101
SPAT
Orthostatic test
3.9
7.4
29
77
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
13.5
7.4
12
9
N30.9
ICD-10 Finland
Cystitis, unspecified
2.7
7.4
48
184
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.4
182
1194
G04BD12
ATC
mirabegron; oral
2.5
7.4
55
228
D12
ICPC
Constipation
3.5
7.4
32
93
D01AC02
ATC
miconazole; topical
2.4
7.4
63
279
OAB95
SPAT
NA
0.1
7.4
*
240
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.5
7.4
57
239
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
2.5
7.3
57
240
I50.9
ICD-10 Finland
Heart failure, unspecified
2.4
7.3
60
260
H53.0
ICD-10 Finland
Amblyopia ex anopsia
5.0
7.3
22
45
G80.3
ICD-10 Finland
Dyskinetic cerebral palsy
+∞
7.3
7
*
Q86.0
ICD-10 Finland
Fetal alcohol syndrome (dysmorphic)
+∞
7.3
7
*
3180A
ICD-9 Finland
Other specified mental retardation, Moderate mental retardation[KESKIVAIKEA ÄLYLL KEHITYSVAMMAISUUS,EI KÄYTÄYT.HÄIR]
+∞
7.3
7
*
199
Kela drug reimbursment
Rufinamide
+∞
7.3
7
*
F72.1
ICD-10 Finland
Severe mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
7.3
7
*
Z3231
NOMESCO Finland
Registered nurse
1.6
7.2
249
1775
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.0
7.2
39
133
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.6
7.2
31
89
K04.1
ICD-10 Finland
Necrosis of pulp
2.0
7.2
92
486
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.4
7.2
60
263
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.4
7.2
33
100
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
7.2
97
523
30199
ICD-8 Finland
Personality disorders, Unspecified
30.3
7.2
9
*
RT274
NOMESCO Finland
NA
30.3
7.2
9
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
30.3
7.2
9
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.7
7.1
49
191
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
4.3
7.1
25
60
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
20.2
7.1
10
5
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
20.2
7.1
10
5
SPAT1154
SPAT
Insertion or removal of subcutaneous medicine capsule
5.1
7.1
21
42
S74
ICPC
Dermatophytosis
4.1
7.1
26
65
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.5
7.1
295
2195
F45.0
ICD-10 Finland
Somatization disorder
12.1
7.1
12
10
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.3
7.1
66
303
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
8.9
7.1
14
16
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
10.1
7.0
13
13
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
10.1
7.0
13
13
-1
NOMESCO Finland
NA
1.5
7.0
352
2729
OAA62
SPAT
NA
0.1
7.0
*
233
P15
ICPC
Chronic alcohol abuse
3.2
7.0
35
114
DFF20
NOMESCO Finland
Audiometry for children
6.4
7.0
17
27
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.3
7.0
24
57
A12BA01
ATC
potassium chloride; oral
4.7
6.9
22
48
R81
ICPC
Pneumonia
3.7
6.9
28
77
37301
ICD-8 Finland
Strabismus, Concomitans divergens
7.6
6.9
15
20
F60.1
ICD-10 Finland
Schizoid personality disorder
13.9
6.9
11
8
R13
ICD-10 Finland
Dysphagia
2.6
6.9
48
191
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
4.4
6.9
23
53
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
4.4
6.9
23
53
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.8
191
1291
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
5.1
6.8
20
40
4122
FHL
Tympanostomy (tympanic tube)
3.8
6.8
27
73
Z3226
NOMESCO Finland
Physiotherapist
1.7
6.8
162
1051
P80
ICPC
Personality disorder
11.0
6.8
12
11
SPD01
NOMESCO Finland
Mucosa-supported complete denture
11.0
6.8
12
11
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
11.0
6.8
12
11
XA400
NOMESCO Finland
EEG
11.0
6.8
12
11
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
11.0
6.8
12
11
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
4.6
6.8
22
49
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
9.4
6.8
13
14
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
5.4
6.8
19
36
ZXY49
NOMESCO Finland
Other health care provider
6.2
6.8
17
28
H50.30
ICD-10 Finland
Intermittent esotropy
5.7
6.8
18
32
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
5.7
6.8
18
32
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.7
6.8
18
32
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
40.4
6.8
8
*
3016A
ICD-9 Finland
Personality disorders, Dependent personality disorder
40.4
6.8
8
*
F23.00
ICD-10 Finland
Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor
40.4
6.8
8
*
29899
ICD-8 Finland
Other psychoses, Reactive psychosis, unspecified
40.4
6.8
8
*
Z65.8
ICD-10 Finland
Other specified problems related to psychosocial circumstances
40.4
6.8
8
*
F20.20
ICD-10 Finland
Catatonic schizophrenia continuously
40.4
6.8
8
*
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.3
6.8
23
54
IEV99
NOMESCO Finland
Other psychiatric network intervention
4.3
6.8
23
54
F20.6
ICD-10 Finland
Simple schizophrenia
16.8
6.8
10
6
A99
ICPC
Disease/condition unspecnature/site
2.2
6.7
65
307
M79.6
ICD-10 Finland
Pain in limb
1.5
6.7
260
1900
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
6.7
112
652
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.3
6.7
31
95
SPE01
NOMESCO Finland
Mucosa-supported partial denture
7.2
6.7
15
21
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.0
6.7
25
64
P27
ICPC
Fear of mental disorder
5.0
6.7
20
41
Z01.2
ICD-10 Finland
Dental examination
1.4
6.7
389
3095
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
22.7
6.7
9
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.2
6.7
66
314
F10.24
ICD-10 Finland
Alcohol depence active use
4.3
6.6
23
55
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.6
6.6
28
80
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.8
6.6
39
141
TJD20
NOMESCO Finland
Change of gastrostomy tube
7.9
6.6
14
18
A02BA04
ATC
nizatidine; systemic
2.6
6.6
47
190
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.7
6.6
27
75
R73.0
ICD-10 Finland
Abnormal glucose tolerance test
4.6
6.6
21
46
S00.0
ICD-10 Finland
Superficial injury of scalp
4.6
6.6
21
46
WZB00
SPAT
NA
0.3
6.6
11
399
R02
ICPC
Shortness of breath/dyspnoea
1.9
6.6
91
496
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
12.4
6.6
11
9
P01
ICPC
Feeling anxious/nervous/tense
1.8
6.6
121
729
GD1AA
SPAT
NA
0.2
6.6
7
326
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
10.1
6.5
12
12
E30.09
ICD-10 Finland
Delayed puberty NOS
10.1
6.5
12
12
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
10.1
6.5
12
12
X84
ICD-10 Finland
Intentional self-harm by unspecified means
10.1
6.5
12
12
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
10.1
6.5
12
12
R01AD12
ATC
fluticasone furoate; nasal
0.6
6.5
123
1857
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
6.5
265
1955
E86
ICD-10 Finland
Volume depletion
4.0
6.5
24
61
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.9
6.5
37
129
A08
ICPC
Swelling
3.1
6.5
33
109
XX4AW
NOMESCO Finland
NA
6.2
6.5
16
26
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.2
6.5
63
299
Z93.1
ICD-10 Finland
Gastrostomy status
70.3
6.4
7
*
F94.0
ICD-10 Finland
Elective mutism
70.3
6.4
7
*
R5130
SPAT
NA
70.3
6.4
7
*
F25.80
ICD-10 Finland
Other specified schizoaffective disorder with only concomitant bipolar and schizophrenic symptoms
70.3
6.4
7
*
78151
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Aphasia
70.3
6.4
7
*
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
70.3
6.4
7
*
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
7.5
6.4
14
19
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
7.5
6.4
14
19
A04
ICPC
Weakness/tiredness general
1.8
6.4
113
671
S01.0
ICD-10 Finland
Open wound of scalp
2.2
6.4
62
292
H66.9
ICD-10 Finland
Otitis media, unspecified
1.9
6.4
99
563
W78
ICPC
Pregnancy
0.4
6.4
28
656
L16
ICPC
Ankle symptom/complaint
1.8
6.4
104
600
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
14.4
6.4
10
7
RT490
NOMESCO Finland
NA
14.4
6.4
10
7
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.2
6.4
7
322
KAY40
NOMESCO Finland
NA
0.0
6.4
*
159
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.8
6.4
107
623
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
6.6
6.4
15
23
7803A
ICD-9 Finland
General symptoms, Convulsions
5.2
6.3
18
35
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.0
6.3
34
117
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
11.1
6.3
11
10
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
6.3
154
1004
S09
ICPC
Infected finger/toe
2.9
6.3
36
127
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
18.2
6.3
9
5
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
18.2
6.3
9
5
2953C
ICD-9 Finland
Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]
18.2
6.3
9
5
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
6.3
289
2188
F70.8
ICD-10 Finland
Mild mental retardation, Other impairments of behaviour
+∞
6.3
6
*
3046
Kela drug reimbursment
NA
+∞
6.3
6
*
31299
ICD-8 Finland
Moderate mental retardation, Other and unspecified
+∞
6.3
6
*
3454X
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]
+∞
6.3
6
*
29530
ICD-8 Finland
Schizophrenia, Paranoid type
26.9
6.2
8
*
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
26.9
6.2
8
*
J01CR50
ATC
combinations of penicillins; systemic
26.9
6.2
8
*
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
7.1
6.2
14
20
A69
ICPC
General and Unspecified, Other reason for encounter NEC
3.6
6.2
26
74
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.6
6.2
42
167
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.3
6.2
15
24
UDC00
NOMESCO Finland
Ear microscopy
2.1
6.2
68
341
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
5.4
6.2
17
32
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.7
6.2
40
153
UKC02
NOMESCO Finland
Cystoscopy
1.9
6.2
91
507
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.3
6.1
21
50
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
7.7
6.1
13
17
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.4
6.1
47
199
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.6
6.1
43
172
F20.1
ICD-10 Finland
Hebephrenic schizophrenia
12.6
6.1
10
8
J96.1
ICD-10 Finland
Chronic respiratory failure
4.9
6.1
18
37
F60.0
ICD-10 Finland
Paranoid personality disorder
8.7
6.1
12
14
R44.0
ICD-10 Finland
Auditory hallucinations
8.7
6.1
12
14
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
6.1
352
2787
F25.01
ICD-10 Finland
Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms
10.1
6.0
11
11
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
10.1
6.0
11
11
E000003
ATC
NA
2.4
6.0
47
201
SPAT1243
SPAT
Psychiatric/psychological examination
2.5
6.0
43
175
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009466) Valproate [Moles/volume] in Serum or Plasma
183
133
16.73
204.21
6.3
5.4
umol/l
406.3
376.2
1.30
172
121
(3026008) Bacteria identified in Urine by Culture
364
1760
2.71
46.13
4.4
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
318
1663
2.36
31.94
4.9
4.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
987
0.07
31.41
1.1
1.3
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
29
25
11.93
28.37
3.2
3.2
umol/l
31.2
35.2
0.59
19
19
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
522
3459
2.10
27.99
5.1
6.6
umol/l
11.6
12.0
0.09
492
3275
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
112
368
3.31
27.54
2.1
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
508
3365
2.07
26.89
9.7
7.7
mmol/l
1.2
1.2
0.08
435
2919
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
211
997
2.43
26.00
2.1
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
359
2117
2.11
25.74
3.1
2.6
u/l
47.1
57.4
7.49
344
1975
(3013826) Glucose [Moles/volume] in Serum or Plasma
585
4162
2.03
24.48
7.2
5.0
mmol/l
6.8
6.5
1.70
547
3839
(3019309) Folate [Moles/volume] in Red Blood Cells
200
950
2.39
24.21
1.7
1.6
nmol/l
1209.1
1155.6
0.30
169
737
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
464
3064
1.99
23.82
11.0
7.3
mmol/l
1.2
1.2
0.41
431
2838
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
25
23
11.13
23.40
3.2
2.0
umol/l
27.8
16.7
2.55
25
23
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
700
5410
2.06
22.03
7.3
7.1
u/l
92.5
84.0
1.18
666
5096
(3000850) Epithelial cells [#/volume] in Urine
262
1447
2.11
21.72
3.7
2.7
e6/l
10.3
6.2
3.08
231
1263
(3024561) Albumin [Mass/volume] in Serum or Plasma
422
2771
1.93
21.33
5.0
5.6
g/l
35.3
36.9
6.05
386
2608
(3026782) Osmolality of Urine
251
1374
2.12
21.24
3.7
2.8
mosm/kgh2o
542.8
574.2
0.94
217
1182
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
156
705
2.45
20.88
2.0
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
153
697
2.42
20.08
2.0
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
394
2572
1.90
19.91
3.8
3.6
u/l
29.8
32.6
0.82
377
2445
(3020682) Albumin/Creatinine [Ratio] in Urine
294
1744
1.98
19.75
3.9
4.2
mg/mmol
14.2
9.6
0.44
199
1169
(3031040) Bacteria [#/volume] in Urine by Automated count
616
4646
1.90
19.63
7.2
3.8
e6/l
2378.1
1303.2
0.23
19
60
(3035350) Ketones [Presence] in Urine by Test strip
502
3557
1.85
19.43
5.4
3.2
estimate
0.0
0.0
0.00
109
681
(3029937) Albumin [Presence] in Urine by Test strip
309
1885
1.94
19.00
6.1
3.4
estimate
0.0
0.0
0.88
115
683
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
213
1150
2.09
18.40
1.8
1.6
pmol/l
60753132.2
18072722.3
0.47
186
996
(3032080) INR in Blood by Coagulation assay
369
2407
1.86
18.32
9.3
6.7
inr
1.2
1.2
0.82
126
744
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
599
0.09
17.49
1.2
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
497
3595
1.79
17.20
5.4
3.2
estimate
0.0
0.0
0.50
108
664
(3021601) Nitrite [Presence] in Urine by Test strip
493
3559
1.79
17.17
6.9
4.4
estimate
0.0
0.0
0.00
115
699
(3021447) Carbon dioxide [Partial pressure] in Venous blood
165
838
2.17
16.58
6.8
6.2
kpa
6.0
5.9
1.44
157
818
(3002582) Erythrocytes [#/volume] in Urine
329
2123
1.83
16.55
5.1
3.3
e6/l
26.2
45.1
1.66
271
1626
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
860
0.11
16.50
1.3
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
266
1614
1.89
16.21
6.3
3.2
kg/l
1.0
1.0
0.04
60
214
(3002032) Base excess in Venous blood by calculation
163
833
2.15
16.09
6.9
6.3
mmol/l
2.1
1.7
0.74
136
667
(3012516) Albumin [Mass/volume] in Urine
270
1659
1.87
15.76
3.4
3.4
mg/l
294.0
262.6
0.05
187
1122
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
293
1848
1.84
15.73
2.8
2.2
u/l
385.7
243.1
0.92
281
1756
(3024354) Oxygen [Partial pressure] in Venous blood
149
747
2.18
15.41
6.7
5.8
kpa
5.2
4.9
0.56
141
729
(42870588) Differential panel, method unspecified - Blood
390
2694
1.75
15.30
7.9
7.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
167
2864
0.50
15.16
3.8
2.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
363
2465
1.76
15.07
5.1
3.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
135
657
2.23
15.01
9.6
9.2
mmol/l
2.7
0.8
4.21
109
524
(3009508) Creatinine [Moles/volume] in Urine
325
2142
1.78
14.93
3.9
3.6
mmol/l
7.1
8.5
5.64
295
1853
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
395
2754
1.73
14.88
5.7
3.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
369
2536
1.74
14.56
5.9
3.8
e6/l
195.0
70.3
0.79
282
1744
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
356
2435
1.73
14.21
1.9
1.8
pmol/l
96.4
97.1
0.09
195
1278
(3019060) Gas panel - Arterial blood
83
332
2.64
14.20
6.6
6.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
871
7706
2.30
13.97
23.2
12.9
mmol/l
139.4
139.6
1.45
851
7494
(3023103) Potassium [Moles/volume] in Serum or Plasma
870
7721
2.25
13.38
22.9
12.9
mmol/l
4.0
3.9
5.08
849
7485
(3016502) Oxygen saturation in Arterial blood
119
581
2.20
13.07
10.4
9.8
%
95.1
95.9
1.09
114
562
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
236
1474
1.79
12.70
3.3
3.5
ng/l
1421.0
1087.1
0.35
196
1214
(3011397) Hemoglobin [Presence] in Urine by Test strip
254
1623
1.77
12.64
5.3
3.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
573
4539
1.64
12.45
19.1
9.5
e9/l
4.2
3.9
2.70
520
3941
(36304419) Bacteria [Presence] in Urine
288
1928
1.70
12.05
4.9
3.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
290
1947
1.70
11.99
5.1
3.3
e6/l
0.4
0.3
0.20
242
1458
(3018418) pH of Serum or Plasma
283
1890
1.70
11.92
5.0
4.0
ph
7.4
7.4
0.02
62
353
(3006315) Basophils [#/volume] in Blood
515
4010
1.61
11.69
9.8
6.8
e9/l
0.0
0.0
0.76
467
3466
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
701
5895
1.69
11.60
4.7
3.7
pmol/l
14.5
14.6
0.36
654
5400
(3027801) Oxygen [Partial pressure] in Arterial blood
126
658
2.05
11.59
9.9
9.1
kpa
10.6
13.0
6.97
121
630
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
126
658
2.05
11.59
9.9
9.2
kpa
5.7
5.1
6.13
121
628
(3001604) Monocytes [#/volume] in Blood
513
3998
1.60
11.55
9.8
6.8
e9/l
0.6
0.6
1.79
465
3455
(3037467) Urinalysis macro (dipstick) panel - Urine
612
4989
1.62
11.31
6.2
3.9
—
—
—
0
0
(4198724)
31
78
4.07
11.27
3.0
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
326
2288
1.64
11.23
4.0
3.1
ng/l
29.5
37.4
0.42
217
1364
(3047181) Lactate [Moles/volume] in Blood
50
173
2.99
11.22
5.4
9.2
mmol/l
1.4
1.2
0.40
45
149
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
16
8
20.31
11.15
1.0
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
524
4138
1.58
10.90
11.6
7.3
e9/l
0.2
0.2
0.35
478
3640
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
124
658
2.01
10.90
8.1
5.6
mmol/l
2.7
1.5
2.45
91
476
(3009343) pH of Capillary blood
126
677
1.99
10.69
8.1
5.5
ph
7.4
7.4
0.32
15
64
(3015377) Calcium [Moles/volume] in Serum or Plasma
310
2185
1.62
10.33
2.8
3.2
mmol/l
2.4
2.4
0.16
270
1965
(3009542) Hematocrit [Volume Fraction] of Blood
686
7733
0.61
10.20
26.9
12.7
%
38.2
40.7
5.88
404
6243
(3014576) Chloride [Moles/volume] in Serum or Plasma
140
793
1.89
10.15
10.3
7.7
mmol/l
103.6
104.2
0.59
133
772
(1616796) Gas panel - Central venous blood
46
161
2.95
10.14
4.5
3.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
117
625
1.99
10.08
10.4
8.3
mmol/l
1.3
1.3
0.09
107
592
(3007853) Bacteria identified in Skin by Aerobe culture
154
910
1.82
9.76
2.4
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
517
4132
1.54
9.75
10.2
6.8
e9/l
2.1
2.0
0.28
471
3653
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
73
331
2.30
9.56
10.5
12.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
792
7011
1.71
9.41
5.8
4.3
mu/l
2.0
2.2
0.43
736
6512
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
47
174
2.79
9.37
1.2
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
53
1180
0.42
9.17
2.6
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
87
432
2.11
9.13
2.6
3.6
ng/l
102.3
170.5
1.43
79
390
(40758558) Short blood count panel - Blood
287
2039
1.58
9.04
11.6
7.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
134
777
1.84
9.00
12.6
9.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
71
327
2.26
8.97
1.9
1.7
—
—
—
0
0
(3010421) pH of Blood
45
167
2.78
8.94
4.7
3.2
ph
7.4
7.4
0.32
39
142
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
69
1367
0.47
8.77
1.6
1.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
10
10
10.09
8.65
2.0
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
88
448
2.06
8.65
1.8
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
477
3813
1.49
8.56
11.3
7.2
%
8.4
8.5
0.46
460
3622
(40768804) Tissue Pathology biopsy report
181
2667
0.60
8.43
1.8
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
40
144
2.85
8.42
4.7
3.3
mmol/l
2.9
2.1
0.75
28
88
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
51
210
2.51
8.27
1.8
2.0
ug/l
2.7
2.5
0.04
46
191
(3006504) Eosinophils/100 leukocytes in Blood
472
3788
1.48
8.17
10.2
7.0
%
2.6
2.9
2.60
455
3577
(3017181) Myelocytes/100 leukocytes in Blood
106
592
1.89
7.99
5.4
4.9
%
0.9
1.0
0.03
43
176
(3021960) Folate [Moles/volume] in Serum or Plasma
203
1365
1.62
7.93
1.5
1.4
nmol/l
17.9
20.4
1.71
186
1176
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
24
5.90
7.87
4.0
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
24
5.90
7.87
4.0
2.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
125
739
1.79
7.85
4.3
4.6
%
1.6
1.6
0.00
112
677
(3022096) Basophils/100 leukocytes in Blood
458
3675
1.47
7.81
10.5
7.1
%
0.6
0.7
3.12
441
3483
(3018405) Lactate [Moles/volume] in Arterial blood
47
193
2.51
7.68
8.4
4.4
mmol/l
1.5
1.4
0.27
47
188
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
387
3015
1.47
7.63
3.1
2.5
nmol/l
71.5
73.0
0.50
355
2780
(3040151) Glucose [Moles/volume] in Capillary blood
29
92
3.22
7.58
7.5
7.4
mmol/l
7.9
6.8
0.73
24
79
(3021901) Oxygen saturation in Capillary blood
36
130
2.84
7.55
3.0
4.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
138
850
1.73
7.52
1.4
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
103
587
1.84
7.29
7.0
6.9
mmol/l
24.2
23.9
0.54
97
563
(3043409) Potassium [Moles/volume] in Arterial blood
41
162
2.60
7.26
7.4
4.4
mmol/l
3.8
3.9
0.00
34
146
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
18
42
4.35
7.24
4.8
3.2
umol/l
239.9
158.7
—
9
25
(3018010) Neutrophils/100 leukocytes in Blood
477
3895
1.44
7.22
10.2
6.7
%
56.0
55.0
0.87
457
3706
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
55
1106
0.47
7.21
2.1
2.6
ug/l
0.7
0.7
0.06
38
648
(3002030) Lymphocytes/100 leukocytes in Blood
481
3952
1.43
6.94
10.4
6.9
%
29.6
30.3
0.67
463
3744
(3012095) Magnesium [Moles/volume] in Serum or Plasma
168
1126
1.60
6.57
5.7
5.5
mmol/l
0.8
0.8
0.35
157
1073
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
721
6419
1.48
6.52
7.5
4.8
mmol/mol
41.0
38.7
5.21
678
6051
(3041096) Erythrocytes [Presence] in Urine by Automated
274
2045
1.47
6.51
4.6
2.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
160
1063
1.61
6.49
10.3
7.6
mmol/l
1.2
1.1
0.98
153
1005
(3021440) Promyelocytes/100 leukocytes in Blood
96
559
1.80
6.34
5.6
4.9
%
0.3
0.1
0.49
37
158
(40767503) Oxygen content in Capillary blood by calculation
35
137
2.61
6.34
3.2
2.8
%
17.1
17.2
0.07
21
80
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
88
501
1.83
6.26
7.9
5.2
ng/l
80.6
71.1
0.45
80
467
(3023511) Choriogonadotropin [Units/volume] in Urine
51
241
2.18
6.12
1.7
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
238
1748
1.48
6.08
2.4
2.4
mg/l
2.9
2.9
0.01
218
1510
(3020891) Body temperature
48
222
2.22
6.07
10.9
5.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
60
306
2.02
5.91
3.6
5.6
g/l
0.3
0.3
0.20
33
170
(3022313) Gas panel - Capillary blood
91
538
1.76
5.72
8.2
5.6
—
—
—
0
0
(3000492) Spirometry study
36
773
0.45
5.61
1.6
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
173
1212
1.52
5.52
3.6
3.5
ng/l
227.1
664.6
1.77
121
824
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
83
484
1.78
5.47
4.0
3.8
mmol/l
1.2
1.2
0.96
77
433
(3002179) Metamyelocytes/100 leukocytes in Blood
91
546
1.74
5.44
4.7
4.6
%
1.1
0.6
0.55
24
130
(3022621) pH of Urine by Test strip
69
382
1.87
5.38
5.8
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
144
975
1.56
5.36
2.4
2.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
9
8
11.34
5.29
2.3
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
89
535
1.73
5.29
6.1
5.0
%
0.0
0.1
1.15
29
137
(3013512) EKG study
228
1702
1.44
5.28
3.8
3.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
161
1124
1.52
5.21
4.8
3.1
e6/l
5.8
1.9
2.98
98
624
(3021589) Normoblasts [#/volume] in Blood
437
3652
1.36
5.15
14.0
9.4
e9/l
0.0
0.0
0.32
374
2950
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
21
543
0.37
5.13
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
277
0.25
5.06
1.3
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
243
0.20
5.05
1.6
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
276
0.25
4.90
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
276
0.25
4.90
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
276
0.25
4.90
1.3
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
83
503
1.71
4.81
5.0
3.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
8
7
11.51
4.79
4.1
10.9
—
—
—
0
0
(3044889) 12 lead EKG panel
547
4768
1.34
4.71
4.0
3.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
97
618
1.63
4.66
4.5
2.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
99
634
1.63
4.66
17.8
16.8
inr
1.4
1.2
0.54
14
96
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
163
1167
1.48
4.65
4.7
2.9
e6/l
1.3
0.9
1.24
98
662
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
299
0.29
4.54
1.2
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
752
6909
1.40
4.44
5.4
3.7
mmol/l
6.3
5.8
10.06
697
6379
(3017732) Neutrophils [#/volume] in Blood
81
500
1.68
4.40
7.9
2.4
e9/l
4.5
4.1
0.46
69
418
(40761536) Microorganisms panel - Urine sediment
99
648
1.59
4.27
5.2
3.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
23
90
2.59
4.24
1.3
1.4
mosm/kgh2o
295.3
288.3
0.36
16
69
(3018677) aPTT in Platelet poor plasma by Coagulation assay
150
1078
1.46
4.19
2.5
3.6
s
30.0
30.0
0.00
143
1054
(3005033) Fetal Nuchal fold Thickness US
5
216
0.23
4.14
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
216
0.23
4.14
1.4
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
12
33
3.67
3.93
2.0
3.5
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
9
15
6.04
3.82
1.4
3.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
27
556
0.47
3.80
2.0
2.3
—
18.1
—
0
33
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
223
0.26
3.79
1.3
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
267
0.33
3.74
1.2
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
24
512
0.46
3.73
1.0
1.2
—
40.3
—
0
23
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
103
703
1.52
3.71
2.9
3.1
g/l
0.2
0.2
0.27
97
665
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
888
0.58
3.66
2.3
2.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
81
526
1.59
3.63
3.6
3.7
e9/l
72.2
69.3
0.31
65
383
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
6
6
10.05
3.50
1.8
1.2
nmol/l
60.2
8.0
—
6
6
(3028707) Methadone [Presence] in Urine by Screen method
51
296
1.76
3.49
4.0
2.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
27
126
2.18
3.44
2.1
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
142
1049
1.41
3.42
2.4
2.9
mmol/l
2.4
2.4
0.38
113
923
(4024509)
13
42
3.12
3.38
1.9
1.3
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
8
14
5.75
3.34
3.3
2.4
umol/l
1.3
1.3
—
8
14
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
162
2.01
3.32
3.1
3.9
e9/l
4.7
4.0
0.84
32
162
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
119
1615
0.70
3.30
2.9
2.3
—
—
—
0
0
(1002224) Polysomnography panel
15
366
0.40
3.29
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
141
1052
1.40
3.21
3.3
2.5
umol/l
11.9
14.3
4.32
133
985
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
32
165
1.97
3.17
3.6
4.3
%
56.5
54.3
0.39
32
165
(3004789) Transferrin [Mass/volume] in Serum or Plasma
131
968
1.41
3.15
3.2
2.5
g/l
2.4
2.4
0.15
122
903
(3008898) HLA-B27 [Presence]
17
386
0.43
3.14
1.1
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
122
893
1.42
3.10
3.4
2.6
%
20.3
24.2
2.69
104
799
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
57
2.66
2.97
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
102
730
1.44
2.94
6.4
6.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
63
409
1.58
2.87
1.9
1.6
mu/l
616.6
292.0
3.00
56
372
(3035637) Corticotropin [Mass/volume] in Plasma
27
136
2.01
2.87
1.4
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
105
759
1.43
2.87
2.3
2.3
nmol/l
399.4
364.0
0.88
98
719
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
9
6.70
2.87
17.7
3.9
mmol/l
5.7
8.3
—
6
9
(3022145) Colonoscopy Study observation
48
762
0.61
2.86
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
69
459
1.54
2.84
2.0
3.5
pmol/l
5.2
4.8
0.64
63
411
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
36
3.08
2.81
1.3
5.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
11
36
3.08
2.81
1.1
1.1
u/l
134.4
551.6
0.78
11
31
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
74
0.00
2.78
0.0
1.4
—
49.8
—
0
19
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
112
1492
0.72
2.77
2.8
2.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
39
226
1.76
2.74
3.9
3.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
45
272
1.69
2.73
3.4
3.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
861
8249
1.40
2.71
12.1
9.3
u/l
28.3
28.0
0.13
836
8001
(3003338) MCHC [Mass/volume]
683
7267
0.80
2.63
32.3
14.7
g/l
332.2
334.3
6.63
678
7213
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
828
7903
1.33
2.52
20.9
11.7
mg/l
25.4
22.2
1.92
727
5926
(3024928) Oxygen saturation in Venous blood
28
152
1.87
2.44
3.6
6.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
169
2082
0.77
2.43
2.3
2.0
—
—
—
0
0
(4034850)
37
220
1.71
2.41
8.2
9.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
187
2271
0.78
2.40
1.8
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
223
1859
1.26
2.32
1.8
1.7
mmol/l
1.7
1.4
1.57
191
1612
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
13
4.64
2.27
7.3
6.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
47
304
1.57
2.23
2.3
2.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
60
411
1.49
2.20
2.4
1.8
u/l
6.9
7.4
0.20
47
314
(3050129) First trimester maternal screen panel - Serum or Plasma
19
357
0.52
2.13
1.4
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
36
221
1.65
2.11
2.1
1.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
15
303
0.49
2.10
1.3
1.2
u/ml
0.6
3.1
—
6
159
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
10
5.02
2.07
20.2
3.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
10
5.02
2.07
1.4
2.9
u/field
0.4
0.5
—
5
10
(40768795) Lymph node Pathology biopsy report
0
56
0.00
2.06
0.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
25
139
1.82
2.06
3.6
3.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
119
1503
0.76
2.06
3.6
3.7
%
20.1
21.3
0.25
42
617
(3000060) B lymphocytes [#/volume] in Blood
15
69
2.19
2.05
3.1
3.6
e6/l
367.0
319.3
—
10
44
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
63
443
1.45
2.05
3.7
2.4
u/l
3743.5
3790.7
0.01
23
175
(3041806) Other cells [#/volume] in Blood by Manual count
0
58
0.00
2.04
0.0
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
718
6788
1.22
2.03
16.1
10.2
ml/min/173m2
97.3
90.5
8.62
550
5364
(3033658) Prothrombin time (PT) actual/Normal
222
1878
1.24
2.02
4.8
4.8
%
91.9
91.8
0.03
214
1832
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
155
1.76
2.02
1.5
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
17
321
0.52
1.96
2.1
1.7
nmol/l
38.1
38.0
0.00
17
312
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
601
6408
0.84
1.95
3.1
3.5
—
—
—
0
0
(3002256) Pathology report gross observation
59
822
0.70
1.93
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
89
1159
0.74
1.92
1.4
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
51
728
0.68
1.91
2.1
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
569
5283
1.19
1.87
4.3
3.3
u/l
48.6
43.4
0.42
532
5019
(3045414) Leukocytes [Presence] in Urine
41
269
1.55
1.87
2.7
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
34
2.66
1.86
8.9
6.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
54
0.00
1.85
0.0
1.6
—
1.0
—
0
54
(3002619) Bacteria identified in Specimen by Culture
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
275
0.50
1.84
1.1
1.2
u/ml
0.1
7.9
—
5
180
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
12
4.18
1.82
1.6
1.6
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
12
4.18
1.82
2.4
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
12
4.18
1.82
1.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
8
29
2.77
1.79
1.4
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
89
684
1.33
1.75
2.6
2.6
u/l
29.9
105.3
0.55
74
581
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
18
3.35
1.75
5.5
5.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
18
3.35
1.75
6.8
5.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
82
1064
0.75
1.74
1.4
1.4
titre
629.3
545.1
0.18
15
199
(3013707) Erythrocyte sedimentation rate by Westergren method
582
5434
1.18
1.73
4.3
4.0
mm/h
12.0
9.7
4.10
544
5058
(3049233) Organic acids panel - Urine
5
13
3.86
1.71
1.0
1.1
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
48
0.00
1.70
0.0
3.5
—
10.4
—
0
43
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
97
1225
0.77
1.69
1.3
1.3
iu/ml
40.4
27.7
0.43
27
371
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
213
0.46
1.67
1.1
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
90
1.90
1.66
3.0
3.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
20
112
1.80
1.65
2.6
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
182
1.61
1.62
3.0
2.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
25
151
1.67
1.61
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
25
151
1.67
1.61
1.2
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
32
2.51
1.60
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
30
191
1.59
1.58
1.4
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
192
1.58
1.55
1.3
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
36
241
1.51
1.54
2.3
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
107
861
1.27
1.52
3.5
4.0
umol/l
11.4
8.1
0.21
85
750
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
45
0.00
1.50
0.0
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
14
72
1.96
1.49
1.6
2.6
mmol/l
103.3
105.1
0.43
14
72
(3042733) HLA Ab [Presence] in Serum
9
37
2.45
1.48
4.9
3.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
59
2.05
1.44
1.7
2.0
pg
34.0
33.4
0.15
12
59
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
95
1176
0.79
1.43
1.3
1.2
u/ml
6.2
8.9
0.33
32
463
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
226
0.53
1.43
3.1
1.8
pmol/l
142.1
219.9
2.09
12
213
(3051611) Lipemic interference index of Serum or Plasma
15
81
1.87
1.40
3.3
3.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
211
0.52
1.39
1.5
1.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
14
74
1.90
1.39
1.6
2.5
mmol/l
4.1
4.0
0.23
14
74
(3017569) Oxygen content in Arterial blood
7
29
2.42
1.39
1.9
4.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
120
0.41
1.38
19.2
1.8
%
13.7
13.0
—
5
120
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
23
2.62
1.37
2.0
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
31
207
1.51
1.36
1.4
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
59
445
1.35
1.36
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
176
1.55
1.32
4.9
9.6
u/ml
0.3
0.3
0.09
12
92
(44806118)
19
113
1.70
1.32
1.3
1.9
—
—
—
0
0
(44790048)
19
113
1.70
1.32
1.3
1.9
—
—
—
0
0
(44790047)
19
113
1.70
1.32
1.3
1.9
—
—
—
0
0
(44790049)
19
113
1.70
1.32
1.3
1.9
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
17
98
1.75
1.31
4.0
3.2
e9/l
0.3
0.2
0.54
12
80
(3026389) Candida sp identified in Specimen by Organism specific culture
15
84
1.80
1.27
1.5
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
179
1.52
1.24
1.6
1.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
17
100
1.71
1.24
4.0
3.2
e6/l
555.1
496.7
0.15
12
80
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
661
6889
0.87
1.19
4.1
3.5
mmol/l
1.5
1.3
6.93
608
6454
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
26
2.32
1.19
2.7
2.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
72
1.82
1.15
1.6
2.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
140
1200
1.19
1.14
2.6
1.8
%
1.7
1.4
0.74
127
1085
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
140
1623
0.84
1.14
2.0
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
58
1.91
1.12
2.9
2.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
11
58
1.91
1.12
1.1
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
722
6957
1.15
1.11
28.5
14.7
%
13.8
13.4
10.60
705
6827
(4035726)
40
533
0.74
1.08
1.3
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
32
2.20
1.08
1.3
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
58
454
1.30
1.07
2.3
1.7
iu/l
11.1
18.6
2.56
50
358
(40760892) CBC W Ordered Manual Differential panel - Blood
205
1825
1.16
1.06
8.3
4.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
18
113
1.60
1.06
3.8
3.2
e9/l
1.4
1.2
0.16
11
67
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
121
0.49
1.05
1.8
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
114
1.59
1.03
1.3
1.7
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
7
34
2.07
1.03
1.0
1.1
%
—
78.0
—
0
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
39
516
0.75
1.01
1.8
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
59
736
0.79
0.99
2.6
2.2
nmol/l
8.5
13.0
3.41
51
663
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
135
0.52
0.98
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
124
1.54
0.97
6.1
4.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
282
0.67
0.96
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
32
234
1.38
0.94
2.3
1.9
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
120
0.50
0.93
1.5
1.9
—
1706.7
—
0
6
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
27
2.23
0.93
1.0
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
62
762
0.80
0.93
1.9
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
78
1.68
0.92
1.9
5.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
182
1626
1.15
0.91
2.2
2.4
mg/l
1.4
1.1
0.61
145
1197
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
21
143
1.48
0.90
1.8
2.5
ug/min
5.8
107.1
—
10
86
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
335
0.71
0.89
1.8
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
9
153
0.58
0.89
1.9
2.0
g/l
36.9
38.7
—
9
139
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
42
1.91
0.88
3.0
2.4
u/ml
543.4
970.4
—
8
42
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
56
1.79
0.88
1.7
2.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
45
1.78
0.84
1.4
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
10
165
0.60
0.82
2.3
2.3
g/l
0.6
1.0
—
10
155
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
130
1.47
0.81
1.3
1.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.4
—
19.3
—
0
6
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.4
—
29.5
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
24
0.00
0.79
0.0
1.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
106
1.52
0.79
1.3
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
48
1.67
0.79
2.3
1.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
26
0.00
0.78
0.0
1.2
—
9.1
—
0
26
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
57
468
1.23
0.76
2.1
2.4
ug/l
6.5
8.1
0.27
51
413
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
99
1.52
0.76
1.1
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
75
1.61
0.75
1.2
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
56
1.61
0.72
1.1
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
331
3518
0.91
0.71
3.4
2.9
ug/l
101.1
104.9
0.17
310
3298
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
60
502
1.21
0.69
2.4
4.5
ug/l
160.9
22.2
0.51
48
403
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
77
1.57
0.68
1.2
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
7
42
1.67
0.68
1.1
1.4
g/l
42.8
31.1
—
7
37
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
102
1.48
0.67
1.1
1.5
—
—
—
0
0
(3019225) pH of Specimen
65
550
1.19
0.67
4.8
4.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
136
1.41
0.67
1.4
2.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
191
0.68
0.67
2.1
2.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
248
0.72
0.66
1.2
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
129
0.62
0.64
1.5
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
129
1.40
0.63
3.2
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
72
834
0.85
0.63
1.3
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
172
1878
0.90
0.63
3.1
4.1
ug/l
1.5
2.0
1.39
153
1722
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
102
0.59
0.62
1.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
14
199
0.70
0.62
1.5
1.2
u/ml
1.9
11.1
—
5
31
(3044640) Blood type and Crossmatch panel - Blood
237
2204
1.10
0.62
2.9
2.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
37
298
1.25
0.61
1.2
1.4
—
7.5
—
0
10
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
14
197
0.71
0.59
1.4
1.2
u/ml
4.2
3.2
—
5
23
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
97
1.45
0.59
1.6
1.9
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.58
0.0
1.0
—
37.4
—
0
23
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
149
1.35
0.58
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
25
193
1.30
0.58
1.2
2.2
e6/l
69.6
7.0
0.74
19
150
(4010399)
59
504
1.18
0.57
1.3
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
699
7151
0.92
0.55
4.4
3.8
mmol/l
1.3
1.4
22.61
645
6712
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
90
1.45
0.55
1.3
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
56
653
0.85
0.55
3.9
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
294
0.78
0.54
1.1
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
74
1.49
0.53
5.3
9.4
%
12.3
11.8
0.43
11
74
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
96
0.62
0.52
1.0
1.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
97
0.62
0.52
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
97
0.62
0.52
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
57
659
0.86
0.51
3.8
2.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
157
0.70
0.51
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
75
1.47
0.51
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
92
1.42
0.50
1.5
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
65
1.39
0.50
2.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
291
0.79
0.50
1.5
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
84
1.43
0.49
1.2
1.3
nmol/l
0.6
0.6
0.18
12
78
(3027008) Opiates [Presence] in Urine
57
656
0.86
0.49
3.8
2.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
65
569
1.15
0.48
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
289
0.79
0.48
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
91
816
1.13
0.48
1.8
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
155
1.30
0.47
1.3
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
840
8287
1.10
0.46
20.3
10.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
57
652
0.87
0.46
3.8
2.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
32
1.57
0.42
1.2
1.1
—
21.4
—
0
7
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
294
0.81
0.42
2.1
1.5
u/ml
194.7
215.6
—
10
153
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
167
1.26
0.42
5.7
6.5
—
1488.0
—
0
20
(3051651) Icteric interference index of Serum or Plasma
10
70
1.43
0.42
2.9
3.9
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
33
1.52
0.41
2.6
3.5
ug/l
94.7
110.4
—
5
33
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
102
0.68
0.39
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
7
101
0.69
0.39
1.1
1.3
—
62.8
—
0
6
(3025130) Human papilloma virus identified in Specimen
7
101
0.69
0.39
1.6
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
35
410
0.85
0.39
2.5
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
35
1.43
0.39
1.2
1.3
nmol/l
163.0
154.9
—
5
35
(3045788) Cell count panel - Pleural fluid
5
35
1.43
0.39
1.2
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
226
2380
0.93
0.38
1.4
1.5
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
36
1.39
0.38
1.0
1.2
%
118.4
109.8
—
5
31
(3042631) Mycobacterium sp identified in Specimen
9
68
1.33
0.37
2.6
4.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
107
1.31
0.37
2.3
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
20
161
1.25
0.37
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
41
470
0.87
0.36
1.2
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
9
71
1.27
0.36
1.2
1.0
mg/l
222.8
252.1
—
9
65
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
707
7186
0.94
0.36
4.6
3.9
mmol/l
4.4
4.7
17.21
658
6775
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
90
1.34
0.36
1.2
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
122
0.74
0.35
1.2
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
43
1.40
0.35
1.7
3.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
12
156
0.77
0.34
1.7
1.3
ug/l
9.5
3.3
0.36
12
137
(3004716) Salmonella sp identified in Stool by Organism specific culture
48
541
0.88
0.34
1.3
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
157
1666
0.93
0.34
2.8
2.8
umol/l
1918.9
5361.6
1.09
138
1479
(3007164) IgA [Mass/volume] in Serum or Plasma
190
2000
0.94
0.32
1.6
1.5
g/l
2.1
2.2
0.29
111
1197
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
132
0.76
0.32
2.0
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
84
1.31
0.30
1.0
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
57
1.23
0.29
3.6
2.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
110
0.73
0.29
1.4
3.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
301
0.86
0.28
2.1
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
104
1.25
0.26
1.0
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
95
1.27
0.26
1.7
4.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
72
1.25
0.25
1.1
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
56
611
0.91
0.25
3.8
2.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
899
9041
0.92
0.24
34.3
17.1
g/l
134.9
137.9
7.47
885
8917
(3045142) Bone marrow Pathology biopsy report
6
83
0.72
0.24
1.0
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
117
1235
0.94
0.23
2.2
2.8
ug/g
137.5
111.0
0.58
93
996
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
125
0.80
0.23
5.0
3.6
u/ml
35.3
35.4
—
10
118
(40768797) Stomach Pathology biopsy report
83
885
0.93
0.22
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
88
1.25
0.22
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
88
1.25
0.22
1.6
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
7
92
0.76
0.22
1.0
1.1
%
82.9
96.1
—
7
87
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
94
0.74
0.22
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
95
0.73
0.22
2.4
1.6
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
169.5
—
0
11
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
0.3
—
0
6
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
11
0.00
0.21
0.0
2.2
—
6987.1
—
0
11
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
12
0.00
0.21
0.0
10.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
105
0.76
0.21
1.8
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
89
1.24
0.21
1.6
1.4
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
899
9035
0.93
0.20
34.0
16.9
e12/l
4.6
4.6
1.99
872
8772
(3035941) MCH [Entitic mass]
899
9034
0.93
0.20
33.8
16.9
pg
29.7
30.0
3.72
885
8915
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
57
530
1.08
0.19
3.5
2.5
ml/min/173m2
78.3
74.8
0.20
26
206
(3024731) MCV [Entitic volume]
899
9033
0.93
0.19
33.8
16.9
fl
89.5
89.6
0.30
885
8913
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
122
0.82
0.19
1.2
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
81
1.24
0.19
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
196
0.86
0.18
1.5
1.5
ug/g
304.8
312.7
—
10
112
(4062490)
12
100
1.20
0.18
2.0
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
28
252
1.11
0.18
1.2
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
10
121
0.82
0.18
1.0
1.1
%
113.3
115.1
—
10
112
(1001926) Buprenorphine [Presence] in Urine by Screen method
55
513
1.08
0.18
3.7
2.2
—
—
—
0
0
(4027681)
7
61
1.15
0.17
1.4
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.0
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
1.0
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
69
0.72
0.17
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
69
0.72
0.17
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
69
0.72
0.17
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
70
0.71
0.16
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
70
0.71
0.16
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
70
0.71
0.16
1.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
177
1.13
0.16
1.2
2.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
70
1.14
0.16
1.3
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
92
1.20
0.16
1.2
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
92
1.20
0.16
1.6
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
900
9037
0.94
0.16
34.1
17.0
e9/l
7.1
6.6
8.45
874
8772
(3017143) Hepatitis C virus Ab [Presence] in Serum
123
1184
1.04
0.15
2.2
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
36
332
1.09
0.15
1.7
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
255
0.90
0.15
1.2
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
72
684
1.06
0.15
2.5
3.0
g/l
10.2
10.1
0.13
66
634
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
87
0.80
0.14
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
254
0.90
0.14
1.2
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
899
9024
0.95
0.14
33.9
17.0
e9/l
252.1
255.6
0.84
876
8778
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
228
2228
1.03
0.13
1.5
1.5
u/ml
1.2
2.0
0.76
69
548
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
159
0.88
0.13
1.6
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
241
0.91
0.12
1.5
2.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
22
241
0.91
0.12
1.3
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
116
0.86
0.12
1.5
1.2
u/l
24.7
22.4
—
10
104
(4281824)
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
27
252
1.07
0.09
2.5
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
258
0.93
0.09
1.3
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
5
48
1.04
0.09
1.4
1.1
—
43.2
—
0
5
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
167
1704
0.98
0.09
2.9
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
58
1.03
0.08
3.8
5.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
5
61
0.82
0.08
3.4
2.4
—
39.9
—
0
18
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
65
0.77
0.08
1.4
2.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
5
65
0.77
0.08
2.4
2.8
nmol/l
0.5
0.9
—
5
52
(21494434) Karyotype in Bone marrow
7
65
1.08
0.08
1.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
31
327
0.95
0.07
1.9
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
75
0.80
0.07
1.5
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
137
1.10
0.07
1.2
1.2
—
—
—
0
0
(4268621)
10
89
1.12
0.07
2.2
2.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
203
0.93
0.06
1.5
1.8
iu/l
7.7
6.1
—
8
70
(40760888) Immunoglobulin light chains.free panel - Serum
10
111
0.90
0.06
2.0
4.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
141
0.92
0.05
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
45
435
1.04
0.05
5.0
2.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
78
763
1.02
0.05
3.9
3.8
%
30.8
31.0
0.07
60
527
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
171
0.93
0.05
1.1
1.1
—
—
—
0
0
(4306422)
11
120
0.92
0.05
1.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
120
1.08
0.05
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
150
1.07
0.04
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
91
1.10
0.04
1.7
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
27
259
1.04
0.04
2.4
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
333
3310
1.01
0.03
5.3
4.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
108
0.93
0.03
2.0
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
132
1.06
0.02
1.1
1.2
u/ml
1.5
4.6
—
6
49
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
132
1.06
0.02
1.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
56
550
1.02
0.02
2.0
1.8
g/l
1.0
1.3
1.88
51
513
(3049717) Cytology report of Urine Cyto stain
19
183
1.04
0.01
1.6
2.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
18
187
0.96
0.01
1.1
1.1
—
10.4
—
0
9
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
63
638
0.99
0.01
1.3
1.2
iu/ml
24.8
149.2
12.29
22
251
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
223
1.03
0.01
1.3
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
26
254
1.02
0.00
1.8
1.6
g/l
0.2
0.2
0.24
26
245
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
102
0.98
0.00
1.4
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
112
0.98
0.00
1.4
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
128
1.02
0.00
1.1
1.2
u/ml
5.6
5.9
—
8
58
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
726
7255
1.00
0.00
5.0
4.2
mmol/l
2.6
2.8
11.21
674
6795
(3004588) Protein electrophoresis panel - Serum or Plasma
33
331
1.00
0.00
1.5
2.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
103
0.97
0.00
2.2
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
167
1.02
0.00
1.1
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
16
159
1.01
0.00
1.4
1.4
pmol/l
88.6
135.2
0.30
16
154
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
26
265
0.98
0.00
1.8
1.5
g/l
1.2
1.2
0.08
26
254
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
135
0.96
0.00
1.3
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
59
0.85
0.00
1.6
1.3
e6/l
1801.2
14927.1
—
5
41
(40760512) CD34 cells/100 cells in Bone marrow
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.7
—
0.5
—
0
9
(3007463) Buprenorphine [Presence] in Urine
0
9
0.00
0.00
0.0
5.3
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
5.1
—
4.4
—
0
9
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(44813793)
7
74
0.95
0.00
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
75
0.93
0.00
1.1
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
49
1.02
0.00
1.4
1.2
—
83.5
—
0
8
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
71
0.99
0.00
1.3
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.1
—
0
5
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
56
0.89
0.00
1.4
1.4
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
6.7
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
97
0.93
0.00
1.2
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
59
1.02
0.00
3.3
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
120
1.00
0.00
2.7
2.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
67
0.89
0.00
1.0
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
59
1.02
0.00
1.2
1.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
76
0.92
0.00
1.1
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_MILDRET and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_MILDRET | 4.33 [3.68, 5.1] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.518 |
During the follow-up period (1.1.1998 — 31.12.2019), 521 out of 5665 females with F5_MILDRET died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_MILDRET | 3.08 [2.64, 3.6] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.02 |
During the follow-up period (1.1.1998 — 31.12.2019), 597 out of 7441 males with F5_MILDRET died.
Mortality risk
Mortality risk for people of age
years, who have F5_MILDRET.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.413% | 0.528% |
| 5 | 2.374% | 3.894% |
| 10 | 6.159% | 8.881% |
| 15 | 11.876% | 16.609% |
| 20 | 20.559% | 28.021% |
Relationships between endpoints
↥Index endpoint: F5_MILDRET – Mild mental retardation
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data